Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Synlogic Released Poster ‘A Synthetic Live Bacterial Therapeutic Organism for the Treatment of the Human Metabolic Disease Phenylketonuria, Synthetic Biology’ for the Engineering, Evolution & Design (SEED) Conference
http://amers2.apps.cp.thomsonreuters.com/Apps/news-monitor#savedinstance=true
Watching Agile Therapeutics, Synlogic; Traders Circulate TipRanks Article ‘These 2 Penny Stocks Are Set for Massive Gains, Says Oppenheimer’
https://blog.tipranks.com/these-2-penny-stocks-are-set-for-massive-gains-says-oppenheimer/
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.
Synlogic Q3 EPS $(0.29), Inline, Sales $916.00K Beat $140.00K Estimate
Synlogic (NASDAQ:SYBX) reported quarterly losses of $(0.29) per share which met the analyst consensus estimate. This is a 19.44 percent increase over losses of $(0.36) per share from the same period last year. The
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Synlogic Presents Data On Hyperoxaluria Program At American Society Of Nephrology Kidney Week 2021
Synlogic, Inc. (NASDAQ:SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced two poster presentations at the upcoming American Society for Nephrology